CoChat

Cellular senescence and failure of myelin repair in multiple sclerosis

Open access
Koutsoudaki, Paraskevi N., Papadopoulos, Dimitrios, Passias, Panagiotis-Georgios, Koutsoudaki, Pinelopi, Gorgoulis, Vassilis G. · 2020 · Mechanisms of Ageing and Development
Cited by 33

The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.

Abstract

Remyelination is a physiological response to demyelinating events aiming to restore saltatory conduction and preserve axonal integrity. Resident oligodendrocyte precursor cells (OPC) of the CNS tissue under appropriate conditions are mobilized to proliferate, migrate, and differentiate, in order to produce new myelin sheaths in the demyelinated lesion. In multiple sclerosis (MS), the most common immune-mediated demyelinating disease, remyelination efficiency declines with increasing age and disease duration. As myelin regeneration attempts in clinical trials so far are scarce, and have been met with limited success, the need to explore new remyelinating strategies is more compelling. Recently, ageing and cellular senescence have been implicated in the pathophysiology of a number of neurodegenerative diseases, including multiple sclerosis. Evidence on OPC senescence brings forward the possibility of exploiting cellular senescence as a possible target for promoting the endogenous remyelinating capacity of the CNS. Here we discuss the data indicating how cellular senescence affects remyelination, and the putative benefits to be drawn through the use of senolytic or senomorphic therapies targeting senescent cell populations in MS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mad.2020.111366

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 88 references

Research works printed but not linked: 131

  1. Alizadeh, 2015, Myelin damage and repair in pathologic CNS: challenges and prospects, Front. Mol. Neurosci., 8, 1, 10.3389/fnmol.2015.00035 · DOI · Paper page
  2. Baranzini, 2000, Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression, J. Immunol., 165, 6576, 10.4049/jimmunol.165.11.6576 · DOI · Paper page
  3. Barbouti, 2019, In situ evidence of cellular senescence in Thymic Epithelial Cells (TECs) during human thymic involution, Mech. Ageing Dev., 177, 88, 10.1016/j.mad.2018.02.005 · DOI · Paper page
  4. Baron, 2000, Perturbation of myelination by activation of distinct signaling pathways: an in vitro study in a myelinating culture derived from fetal rat brain, J. Neurosci. Res., 59, 74, 10.1002/(SICI)1097-4547(20000101)59:1<74::AID-JNR9>3.0.CO;2-P · DOI
  5. Bevan, 2018, Meningeal inflammation and cortical demyelination in acute multiple sclerosis, Ann. Neurol., 84, 829, 10.1002/ana.25365 · DOI · Paper page
  6. Bin, 2013, Full-length and fragmented netrin-1 in multiple sclerosis plaques are inhibitors of oligodendrocyte precursor cell migration, Am. J. Pathol., 183, 673, 10.1016/j.ajpath.2013.06.004 · DOI
  7. Black, 2006, Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Na v1.6 and K v1.2 at nodes of Ranvier, Brain, 129, 1319, 10.1093/brain/awl057 · DOI
  8. Bodini, 2016, Dynamic imaging of individual remyelination profiles in multiple sclerosis, Ann. Neurol., 79, 726, 10.1002/ana.24620 · DOI · Paper page
  9. Boyd, 2013, Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models, Acta Neuropathol., 125, 841, 10.1007/s00401-013-1112-y · DOI · Paper page
  10. Bramow, 2010, Demyelination versus remyelination in progressive multiple sclerosis, Brain, 133, 2983, 10.1093/brain/awq250 · DOI · Paper page
  11. Brown, 2014, Imaging of repeated episodes of demyelination and remyelination in multiple sclerosis, Neuroimage Clin., 6, 20, 10.1016/j.nicl.2014.06.009 · DOI · Paper page
  12. Burbidge, 2002, Molecular cloning, distribution and functional analysis of the NAV1.6. Voltage-gated sodium channel from human brain, Mol. Brain Res., 103, 80, 10.1016/S0169-328X(02)00188-2 · DOI
  13. Butt, 2005, Opposing actions of fibroblast growth factor-2 on early and late oligodendrocyte lineage cells in vivo, J. Neuroimmunol., 166, 75, 10.1016/j.jneuroim.2005.05.015 · DOI
  14. Cadavid, 2017, Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial, Lancet Neurol., 16, 189, 10.1016/S1474-4422(16)30377-5 · DOI · Paper page
  15. Cadavid, 2019, Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial, Lancet Neurol., 18, 845, 10.1016/S1474-4422(19)30137-1 · DOI · Paper page
  16. Chamberlain, 2016, Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis, Neuropharmacology, 10.1016/j.neuropharm.2015.10.010 · DOI · Paper page
  17. Chang, 2000, NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions, J. Neurosci., 10.1523/JNEUROSCI.20-17-06404.2000 · DOI · Paper page
  18. Charles, 2002, Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?, Brain, 125, 1972, 10.1093/brain/awf216 · DOI · Paper page
  19. Coman, 2006, Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis, Brain, 129, 3186, 10.1093/brain/awl144 · DOI · Paper page
  20. Coppé, 2010, The senescence-associated secretory phenotype: the dark side of tumor suppression, Annu. Rev. Pathol. Mech. Dis., 5, 99, 10.1146/annurev-pathol-121808-102144 · DOI · Paper page
  21. Craner, 2004, Co- localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE, Brain, 127, 294, 10.1093/brain/awh032 · DOI · Paper page
  22. Crawford, 2016, Pre-existing mature oligodendrocytes do not contribute to remyelination following toxin-induced spinal cord demyelination, Am. J. Pathol., 186, 511, 10.1016/j.ajpath.2015.11.005 · DOI · Paper page
  23. Cunniffe, 2019, Promoting remyelination in multiple sclerosis, J. Neurol.
  24. Dawson, 2000, NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors?, J. Neurosci. Res., 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.0.CO;2-N · DOI · Paper page
  25. De Angelis, 2018, Disease-modifying therapies for multiple sclerosis, BMJ, 4674, 1
  26. de Barcelos, 2019, Mitochondrial dysfunction and multiple sclerosis, Biology (Basel), 8
  27. de Jong, 2018, Galectin-4, a negative regulator of oligodendrocyte differentiation, is persistently present in axons and microglia/ macrophages in multiple sclerosis lesions, J. Neuropathol. Exp. Neurol., 77, 1024, 10.1093/jnen/nly081 · DOI
  28. Debacq-Chainiaux, 2005, Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-β1 signaling pathway, J. Cell. Sci., 118, 743, 10.1242/jcs.01651 · DOI · Paper page
  29. Dusart, 1992, Demyelination, and remyelination by Schwann cells and oligodendrocytes after kainate-induced neuronal depletion in the central nervous system, Neuroscience, 51, 137, 10.1016/0306-4522(92)90478-K · DOI · Paper page
  30. Dutta, 2006, Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients, Ann. Neurol., 59, 478, 10.1002/ana.20736 · DOI · Paper page
  31. El Behi, 2017, Adaptive human immunity drives remyelination in a mouse model of demyelination, Brain, 140, 967, 10.1093/brain/awx008 · DOI · Paper page
  32. Evangelou, 2013, The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis, Cell Death Differ., 20, 1485, 10.1038/cdd.2013.76 · DOI · Paper page
  33. Fancy, 2009, Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS, Genes Dev., 23, 1571, 10.1101/gad.1806309 · DOI · Paper page
  34. Felts, 1992, Conduction properties of central nerve fibers remyelinated by Schwann cells, Brain Res., 574, 178, 10.1016/0006-8993(92)90815-Q · DOI
  35. Felts, 2005, Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide, Brain, 128, 1649, 10.1093/brain/awh516 · DOI · Paper page
  36. Foerster, 2019, Diversity in the oligodendrocyte lineage: plasticity or heterogeneity?, Glia, 10.1002/glia.23607 · DOI
  37. Franklin, 2015, Glia disease and repair—remyelination, Cold Spring Harb. Perspect. Biol., 7, 1, 10.1101/cshperspect.a020594 · DOI · Paper page
  38. Galloway, 2019, Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination, Glia
  39. Gilson, 1993, Failure of remyelination in areas of demyelination produced in the spinal cord of old rats, Neuropathol. Appl. Neurobiol., 19, 173, 10.1111/j.1365-2990.1993.tb00424.x · DOI · Paper page
  40. Goddard, 2001, Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo, Mol. Cell. Neurosci., 18, 557, 10.1006/mcne.2001.1025 · DOI · Paper page
  41. Haider, 2014, Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron, J. Neurol. Neurosurg. Psychiatry, 85, 1386, 10.1136/jnnp-2014-307712 · DOI · Paper page
  42. Hamada, 2015, Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability, J. Neurosci., 35, 7272, 10.1523/JNEUROSCI.4747-14.2015 · DOI · Paper page
  43. Hamanaka, 2018, White-matter repair: interaction between oligodendrocytes and the neurovascular unit, Brain Circ., 4, 118, 10.4103/bc.bc_15_18 · DOI · Paper page
  44. Hampton, 2012, Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency, Am. J. Pathol., 180, 1897, 10.1016/j.ajpath.2012.01.018 · DOI
  45. Hayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016/0014-4827(61)90192-6 · DOI · Paper page
  46. He, 2016, Chd7 cooperates with Sox10 and regulates the onset of CNS myelination and remyelination, Nat. Neurosci., 19, 678, 10.1038/nn.4258 · DOI · Paper page
  47. Hernandez-Segura, 2018, Hallmarks of cellular senescence, Trends Cell Biol., 10.1016/j.tcb.2018.02.001 · DOI · Paper page
  48. Hoffmann, 2014, Stem cell factor Sox2 and its close relative Sox3 have differentiation functions in oligodendrocytes, Dev., 141, 39, 10.1242/dev.098418 · DOI · Paper page
  49. Horiuchi, 2012, Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro, Neurobiol. Aging, 33, 499, 10.1016/j.neurobiolaging.2010.05.007 · DOI · Paper page
  50. Hou, 2017, Ginsenoside Rg3 prevents oxidative stress-induced astrocytic senescence and ameliorates senescence paracrine effects on glioblastoma, Molecules, 22, 10.3390/molecules22091516 · DOI · Paper page
  51. Hou, 2018, Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype, Chem. Biol. Interact., 283, 75, 10.1016/j.cbi.2018.02.002 · DOI
  52. Itoyama, 1983, Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions, Ann. Neurol., 14, 339, 10.1002/ana.410140313 · DOI · Paper page
  53. Jarjour, 2003, Netrin-1 is a chemorepellent for oligodendrocyte precursor cells in the embryonic spinal cord, J. Neurosci., 23, 3735, 10.1523/JNEUROSCI.23-09-03735.2003 · DOI · Paper page
  54. Jeffries, 2016, ERK1/2 activation in preexisting oligodendrocytes of adult mice drives new myelin synthesis and enhanced CNS function, J. Neurosci., 36, 9186, 10.1523/JNEUROSCI.1444-16.2016 · DOI · Paper page
  55. John, 2002, Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation, Nat. Med., 8, 1115, 10.1038/nm781 · DOI · Paper page
  56. Kernt, 2013, Idebenone prevents human optic nerve head astrocytes from oxidative stress, apoptosis, and senescence by stabilizing BAX/Bcl-2 ratio, J Glaucoma, 22, 404, 10.1097/IJG.0b013e31824caf90 · DOI
  57. Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am. J. Pathol., 157, 267, 10.1016/S0002-9440(10)64537-3 · DOI · Paper page
  58. Koutsoudaki, 2010, Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV, Neuroscience, 171, 235, 10.1016/j.neuroscience.2010.08.070 · DOI · Paper page
  59. Kremer, 2019, Current advancements in promoting remyelination in multiple sclerosis, Mult. Scler. J., 10.1177/1352458518800827 · DOI
  60. Krenning, 2014, Transient activation of p53 in G2 phase is sufficient to induce senescence, Mol. Cell, 55, 59, 10.1016/j.molcel.2014.05.007 · DOI · Paper page
  61. Kuhlmann, 2008, Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis, Brain, 131, 1749, 10.1093/brain/awn096 · DOI · Paper page
  62. Lalive, 2005, TGF-β-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway, Eur. J. Immunol., 35, 727, 10.1002/eji.200425430 · DOI · Paper page
  63. Lassmann, 2016, Oxidative stress and its impact on neurons and glia in multiple sclerosis lesions, Biochim. Biophys. Acta Mol. Basis Dis, 1862, 506, 10.1016/j.bbadis.2015.09.018 · DOI · Paper page
  64. Lentferink, 2018, Grey matter OPCs are less mature and less sensitive to IFNγ than white matter OPCs: consequences for remyelination, Sci. Rep., 8, 10.1038/s41598-018-19934-6 · DOI
  65. Leray, 2010, Evidence for a two-stage disability progression in multiple sclerosis, Brain, 133, 1900, 10.1093/brain/awq076 · DOI · Paper page
  66. Liebetanz, 2006, Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis, Exp. Neurol., 202, 217, 10.1016/j.expneurol.2006.05.032 · DOI · Paper page
  67. Lin, 2012, Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells, Mol. Biol. Cell, 23, 1569, 10.1091/mbc.e11-10-0849 · DOI · Paper page
  68. Lloyd, 2016, Cellular and molecular mechanisms underpinning macrophage activation during remyelination, Front. Cell Dev. Biol., 10.3389/fcell.2016.00060 · DOI · Paper page
  69. Lovas, 2000, Axonal changes in chronic demyelinated cervical spinal cord plaques, Brain, 123, 308, 10.1093/brain/123.2.308 · DOI · Paper page
  70. Ludwin, 1984, Long-term remyelination fails to reconstitute normal thickness of central myelin sheaths, J. Neurol. Sci., 64, 193, 10.1016/0022-510X(84)90037-6 · DOI
  71. Marqués-Torrejón, 2013, Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression, Cell Stem Cell, 12, 88, 10.1016/j.stem.2012.12.001 · DOI · Paper page
  72. Martínez-Cué, 2020, Cellular senescence in neurodegenerative diseases, Front. Cell. Neurosci., 14, 10.3389/fncel.2020.00016 · DOI · Paper page
  73. McKay, 2015, Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review, Biomed Res. Int., 10.1155/2015/817238 · DOI
  74. McKinnon, 1990, FGF modulates the PDGF-driven pathway of oligodendrocyte development, Neuron, 5, 603, 10.1016/0896-6273(90)90215-2 · DOI · Paper page
  75. Mecha, 2013, Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler’s virus model of multiple sclerosis: implications for remyelination at lesions sites, Exp. Neurol., 250, 348, 10.1016/j.expneurol.2013.10.011 · DOI
  76. Mei, 2016, Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery, Elife, 5, 10.7554/eLife.18246 · DOI · Paper page
  77. Mi, 2005, LINGO-1 negatively regulates myelination by oligodendrocytes, Nat. Neurosci., 8, 745, 10.1038/nn1460 · DOI · Paper page
  78. Milner, 1997, Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration, Glia, 19, 85, 10.1002/(SICI)1098-1136(199701)19:1<85::AID-GLIA9>3.0.CO;2-9 · DOI · Paper page
  79. Miron, 2011, Cells of the oligodendroglial lineage, myelination, and remyelination, Biochim. Biophys. Acta Mol. Basis Dis., 10.1016/j.bbadis.2010.09.010 · DOI · Paper page
  80. Mitew, 2018, Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner, Nat. Commun., 9, 10.1038/s41467-017-02719-2 · DOI · Paper page
  81. Mitrovič, 2018, Low- frequency and rare-coding variation contributes to multiple sclerosis risk, Cell, 175, 1679, 10.1016/j.cell.2018.09.049 · DOI · Paper page
  82. Montalban, 2018, Cladribine tablets added to IFN-β in active relapsing MS, Neurol. Neuroimmunol. NeuroInflammation, 5, 10.1212/NXI.0000000000000477 · DOI
  83. Morgan-Hughes, 1968, Experimental diphtheritic neuropathy. A pathological and electrophysiological study, J. Neurol. Sci., 7, 157, 10.1016/0022-510X(68)90011-7 · DOI
  84. Muñoz- Espín, 2014, Cellular senescence: from physiology to pathology, Nat. Rev. Mol. Cell Biol., 10.1038/nrm3823 · DOI · Paper page
  85. Mutsaers, 1998, Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve, Acta Neuropathol., 96, 139, 10.1007/s004010050873 · DOI
  86. Nakamura, 2008, Both telomeric and non- telomeric DNA damage are determinants of mammalian cellular senescence, Epigenetics Chromatin, 1, 10.1186/1756-8935-1-6 · DOI · Paper page
  87. Neumann, 2019, Metformin restores CNS remyelination capacity by rejuvenating aged stem cells, Cell Stem Cell, 25, 473, 10.1016/j.stem.2019.08.015 · DOI · Paper page
  88. Nicaise, 2019, Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis, Proc. Natl. Acad. Sci. U. S. A., 116, 9030, 10.1073/pnas.1818348116 · DOI · Paper page
  89. Noble, 2003, The cortical ancestry of oligodendrocytes: common principles and novel features, Dev. Neurosci., 10.1159/000072270 · DOI
  90. Oost, 2018, Targeting senescence to delay progression of multiple sclerosis, J. Mol. Med., 10.1007/s00109-018-1686-x · DOI
  91. Ortiz, 2019, Neuronal activity in vivo enhances functional myelin repair, JCI Insight, 4, 10.1172/jci.insight.123434 · DOI · Paper page
  92. Papadopoulos, 2006, Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat, Exp. Neurol., 197, 373, 10.1016/j.expneurol.2005.10.033 · DOI · Paper page
  93. Papageorgis, 2017, Complex interplay between aging and cancer: role of TGF-β signaling, Crit. Rev. Oncog., 10.1615/CritRevOncog.2017025134 · DOI
  94. Pardo, 2017, The sequence of disease- modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations, J. Neurol.
  95. Patani, 2007, Remyelination can be extensive in multiple sclerosis despite a long disease course, Neuropathol Appl Neurobiol, 33, 277, 10.1111/j.1365-2990.2007.00805.x · DOI · Paper page
  96. Patrikios, 2006, Remyelination is extensive in a subset of multiple sclerosis patients, Brain, 129, 3165, 10.1093/brain/awl217 · DOI · Paper page
  97. Petersen, 2017, Fibrinogen activates BMP signaling in oligodendrocyte progenitor cells and inhibits remyelination after vascular damage, Neuron, 96, 1003, 10.1016/j.neuron.2017.10.008 · DOI · Paper page
  98. Poliak, 2003, The local differentiation of myelinated axons at nodes of ranvier, Nat. Rev. Neurosci., 10.1038/nrn1253 · DOI · Paper page
  99. Prozorovski, 2019, Regulation of sirtuin expression in autoimmune neuroinflammation: induction of SIRT1 in oligodendrocyte progenitor cells, Neurosci. Lett., 704, 116, 10.1016/j.neulet.2019.04.007 · DOI
  100. Raine, 2017, Multiple sclerosis: the resolving lesion revealed, J. Neuroimmunol., 304, 2, 10.1016/j.jneuroim.2016.05.021 · DOI
  101. Ren, 2009, Inflammatory signaling and cellular senescence, Cell. Signal., 10.1016/j.cellsig.2008.10.011 · DOI · Paper page
  102. Rivera, 2019, Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination, Glia, 67, 1510, 10.1002/glia.23624 · DOI
  103. Sabin, 2011, Cellular Senescence - its role in cancer and the response to ionizing radiation, Genome Integr., 10.1186/2041-9414-2-7 · DOI · Paper page
  104. Saida, 1980, Antiserum‐mediated demyelination: relationship between remyelination and functional recovery, Ann. Neurol., 8, 12, 10.1002/ana.410080103 · DOI
  105. Scott-Hewitt, 2017, Heterozygote galactocerebrosidase (GALC) mutants have reduced remyelination and impaired myelin debris clearance following demyelinating injury, Hum. Mol. Genet., 26, 2825, 10.1093/hmg/ddx153 · DOI
  106. Sedal, 1983, A combined morphological and electrophysiological study of conduction block in peripheral nerve, J. Neurol. Sci., 60, 293, 10.1016/0022-510X(83)90070-9 · doi:10.1016/0022-510x(83)90070-9
  107. Shen, 2008, Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency, Nat. Neurosci., 11, 1024, 10.1038/nn.2172 · DOI · Paper page
  108. Shields, 1999, Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination, Glia, 28, 77, 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F · DOI · Paper page
  109. Shrager, 1988, Ionic channels and signal conduction in single remyelinating frog nerve fibres, J. Physiol., 404, 695, 10.1113/jphysiol.1988.sp017314 · doi:10.1113/jphysiol.1988.sp017314
  110. Sim, 2002, The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation, J. Neurosci., 22, 2451, 10.1523/JNEUROSCI.22-07-02451.2002 · DOI · Paper page
  111. Smith, 1980, Nerve conduction during peripheral demyelination and remyelination, Top. Catal., 48, 201
  112. Smith, 1979, Central remyelination restores secure conduction [12], Nature
  113. Smith, 1981, The restoration of conduction by central remyelination, Brain, 104, 647, 10.1093/brain/104.2.383 · DOI · Paper page
  114. Stancic, 2012, Galectin-4, a novel neuronal regulator of myelination, Glia, 60, 919, 10.1002/glia.22324 · DOI · Paper page
  115. Tepavčević, 2014, Early netrin-1 expression impairs central nervous system remyelination, Ann. Neurol., 76, 252, 10.1002/ana.24201 · DOI · Paper page
  116. Thümmler, 2019, Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential, Acta Neuropathol. Commun., 7, 10.1186/s40478-019-0864-6 · DOI
  117. Tian, 2018, CXCL12 induces migration of oligodendrocyte precursor cells through the CXCR4‑activated MEK/ERK and PI3K/AKT pathways, Mol. Med. Rep., 18, 4374
  118. Tobin, 2011, Reduced axonopathy and enhanced remyelination after chronic demyelination in fibroblast growth factor 2 (Fgf2)-null mice: differential detection with diffusion tensor imaging, J. Neuropathol. Exp. Neurol., 70, 157, 10.1097/NEN.0b013e31820937e4 · DOI · Paper page
  119. Verden, 2016, Neuroprotection by central nervous system remyelination: molecular, cellular, and functional considerations, J. Neurosci. Res., 10.1002/jnr.23923 · DOI
  120. Wang, 1998, Notch receptor activation inhibits oligodendrocyte differentiation, Neuron, 21, 10.1016/S0896-6273(00)80515-2 · DOI · Paper page
  121. Williams, 2007, Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?, Brain, 130, 2554, 10.1093/brain/awm202 · DOI · Paper page
  122. Xia, 2020, Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease, J. Neuroinflammation, 17, 105, 10.1186/s12974-020-01791-8 · DOI · Paper page
  123. Yabluchanskiy, 2020, Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation–induced impairment of neurovascular coupling responses protecting cognitive function in mice, GeroScience, 10.1007/s11357-020-00154-8 · DOI
  124. Yamada, 1998, White matter astrocytes produce hepatocyte growth factor activator inhibitor in human brain tissues, Exp. Neurol., 153, 60, 10.1006/exnr.1998.6874 · DOI
  125. Yin, 2014, Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish, Exp. Neurol., 251, 72, 10.1016/j.expneurol.2013.11.012 · DOI
  126. Zambonin, 2011, Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis, Brain, 134, 1901, 10.1093/brain/awr110 · DOI · Paper page
  127. Zawadzka, 2010, CNS-resident glial Progenitor/Stem cells produce schwann cells as well as oligodendrocytes during repair of CNS demyelination, Cell Stem Cell, 6, 578, 10.1016/j.stem.2010.04.002 · DOI · Paper page
  128. Zhang, 2010, TGFβ1 induces Jagged1 expression in astrocytes via ALK5 and Smad3 and regulates the balance between oligodendrocyte progenitor proliferation and differentiation, Glia, 58, 964, 10.1002/glia.20978 · DOI · Paper page
  129. Zhang, 2018, Sox2 is essential for oligodendroglial proliferation and differentiation during postnatal brain myelination and CNS remyelination, J. Neurosci., 38, 1802, 10.1523/JNEUROSCI.1291-17.2018 · DOI · Paper page
  130. Zhou, 2019, Age-related changes in the global DNA methylation profile of oligodendrocyte progenitor cells derived from rat spinal cords, Curr. Med. Sci., 39, 67, 10.1007/s11596-019-2001-y · DOI
  131. Zhu, 2014, Ginsenoside Rg1 prevents cognitive impairment and hippocampus senescence in a rat model of D-galactose-induced aging, PLoS One, 9

Cited by

See all 33

Metadata

Authors
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G.
Venue
Mechanisms of Ageing and Development
Publisher
Elsevier BV
Published
2020-12
Volume
192
Pages
111366
ISSN
0047-6374 (ISSN-L)
OpenAlex
W3091536782
Cited by
33
References
88
FWCI
1.54
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • Hellenic Foundation for Research and Innovation
  • H2020 Marie Skłodowska-Curie Actions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cellular senescence and failure of myelin repair in multiple sclerosis. https://app.cochat.ai/papers/10.1016/j.mad.2020.111366
The paper
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020). Cellular senescence and failure of myelin repair in multiple sclerosis. Mechanisms of Ageing and Development. https://doi.org/10.1016/j.mad.2020.111366

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.